240926-Tanimura-Aspirin-Summary (IMAGE)

Kobe University

240926-Tanimura-Aspirin-Summary — Caption

20% of women with recurrent pregnancy loss test positive for an antibody that targets their own bodies. For women with this condition participating in a Kobe University study, a new treatment increased their chances of having a life birth from 50% to 87% and reduced the likelihood of experiencing pregnancy complications from 50% to 6%.

Credit

Kobe University

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.